Michael Zavelevich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Michael Zavelevich has a total of 136 co-authors. Here are the top co-authors by number of shared publications:
- Alex Philchenkov
R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine
11 shared publications - Daniil F. Gluzman
R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine
10 shared publications L M Sklyarenko
4 shared publicationsV A Nadgornaya
4 shared publicationsD.F. Gluzman
R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine
3 shared publicationsS V Koval
3 shared publications
Latest Publications
- 25 May 2026
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Oncology
- Vol. 28 (2) , 64-69
ХРОНІЧНА ЛІМФОЦИТАРНА ЛЕЙКЕМІЯ ТА ІОНІЗУВАЛЬНА РАДІАЦІЯ: ПОГЛЯД ЧЕРЕЗ 40 РОКІВ ПІСЛЯ АВАРІЇ НА ЧОРНОБИЛЬСЬКІЙ АЕС
Хронічна лімфоцитарна лейкемія (ХЛЛ) належить до найбільш поширених форм онкогематологічних захворювань дорослого населення України, США та Західної Європи. Питання щодо радіогенності ХЛЛ залишається дискусійним, хоча в низці епідеміологічних робіт було виявлено підвищення ризику її розвитку за дії іонізувального випромінювання. В огляді стисло проаналізовано результати проведених в Україні епідеміологічних досліджень щодо з’ясування можливого зв’язку між опроміненням внаслідок аварії на ЧАЕС та збільшенням частоти ХЛЛ. Багаторічний дескриптивний аналіз випадків ХЛЛ серед населення регіонів України, що розрізняються за ступенем залишкового забруднення радіонуклідами, виявив тенденцію до перерозподілу структури гематологічних злоякісних новоутворень в бік збільшення питомої ваги ХЛЛ серед онкогематологічних хворих регіонів з більшим ступенем радіаційного забруднення. Розглянуто деякі молекулярно-генетичні особливості клітин ХЛЛ у хворих серед ліквідаторів аварії на ЧАЕС, які можуть в подальшому стати в пригоді для молекулярно-епідеміологічних досліджень онкогематологічних наслідків аварії на ЧАЕС.
- 25 May 2026
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Oncology
- Vol. 28 (2) , 64-69
ХРОНІЧНА ЛІМФОЦИТАРНА ЛЕЙКЕМІЯ ТА ІОНІЗУВАЛЬНА РАДІАЦІЯ: ПОГЛЯД ЧЕРЕЗ 40 РОКІВ ПІСЛЯ АВАРІЇ НА ЧОРНОБИЛЬСЬКІЙ АЕС
Хронічна лімфоцитарна лейкемія (ХЛЛ) належить до найбільш поширених форм онкогематологічних захворювань дорослого населення України, США та Західної Європи. Питання щодо радіогенності ХЛЛ залишається дискусійним, хоча в низці епідеміологічних робіт було виявлено підвищення ризику її розвитку за дії іонізувального випромінювання. В огляді стисло проаналізовано результати проведених в Україні епідеміологічних досліджень щодо з’ясування можливого зв’язку між опроміненням внаслідок аварії на ЧАЕС та збільшенням частоти ХЛЛ. Багаторічний дескриптивний аналіз випадків ХЛЛ серед населення регіонів України, що розрізняються за ступенем залишкового забруднення радіонуклідами, виявив тенденцію до перерозподілу структури гематологічних злоякісних новоутворень в бік збільшення питомої ваги ХЛЛ серед онкогематологічних хворих регіонів з більшим ступенем радіаційного забруднення. Розглянуто деякі молекулярно-генетичні особливості клітин ХЛЛ у хворих серед ліквідаторів аварії на ЧАЕС, які можуть в подальшому стати в пригоді для молекулярно-епідеміологічних досліджень онкогематологічних наслідків аварії на ЧАЕС.
- Open Access
- 16 March 2026
- Published by IntechOpen
New Approaches to the Treatment of Chronic Myeloid Leukemia
While the specific inhibitors of BCR-ABL tyrosine kinase activity have gained well-deserved recognition in the frontline therapy of chronic myeloid leukemia (CML), acquired therapy resistance represents a serious problem, preventing long-term remission in CML patients. Moreover, in some patients, the resistance mechanisms are BCR-ABL-independent. Therefore, the search for alternative and complementary therapies is currently in the spotlight. The differentiation therapy may represent one of the possible approaches. Alpha-tocopherol may be one of the agents possessing differentiation potential in CML blast cells. We demonstrated that alpha-tocopherol and G-CSF upregulate the expression of several genes associated with the differentiation of K562 CML cells in vitro, in particular, the gene coding for the myeloid master regulator transcription factor C/EBPα. At the same time, a significant down-regulation of the expression of genes associated with the stemness phenotype, such as SNAI1, ALPP, and POU5F1 was observed. Other possible targets may be searched among the enzymes preventing the degradation of the BCR-ABL protein. The data on the specific inhibition of deubiquitinase USP1 activity in vitro in K562 cells have been presented. A vast array of other targetable enzymes interacting with the BCR-ABL protein and affecting its stability and activity remains an extensive field for further study. A putative role of protein phosphatase 2A in this context is discussed.
- 16 March 2026
- Published by IntechOpen
Open AccessNew Approaches to the Treatment of Chronic Myeloid Leukemia
While the specific inhibitors of BCR-ABL tyrosine kinase activity have gained well-deserved recognition in the frontline therapy of chronic myeloid leukemia (CML), acquired therapy resistance represents a serious problem, preventing long-term remission in CML patients. Moreover, in some patients, the resistance mechanisms are BCR-ABL-independent. Therefore, the search for alternative and complementary therapies is currently in the spotlight. The differentiation therapy may represent one of the possible approaches. Alpha-tocopherol may be one of the agents possessing differentiation potential in CML blast cells. We demonstrated that alpha-tocopherol and G-CSF upregulate the expression of several genes associated with the differentiation of K562 CML cells in vitro, in particular, the gene coding for the myeloid master regulator transcription factor C/EBPα. At the same time, a significant down-regulation of the expression of genes associated with the stemness phenotype, such as SNAI1, ALPP, and POU5F1 was observed. Other possible targets may be searched among the enzymes preventing the degradation of the BCR-ABL protein. The data on the specific inhibition of deubiquitinase USP1 activity in vitro in K562 cells have been presented. A vast array of other targetable enzymes interacting with the BCR-ABL protein and affecting its stability and activity remains an extensive field for further study. A putative role of protein phosphatase 2A in this context is discussed.
- Open Access
- 12 November 2023
- Published by Igor Sikorsky Kyiv Polytechnic Institute in Innovative Biosystems and Bioengineering
- Vol. 7 (4) , 48-56
The Influence of Flavonoid Compositions on Nrf2 Transcription Factor Expression in Case of Infections Triggered by Influenza A Virus and Transmissible Gastroenteritis Coronavirus
Background. Viral infections trigger transcription factors, including Nrf2, which regulate the expression of genes related to cytokines, chemokines, and more. Nuclear factor erythroid 2-related factor 2 (Nrf2) participates in complex regulatory networks controlling the expression of cytoprotective genes and immune responses. Recently, new roles have been attributed to Nrf2, including the regulation of antiviral responses. Objective. The aim of the study was to analyze Nrf2 activation in influenza virus infection in vivo and in transmissible gastroenteritis coronavirus (TGEV) infection in vitro, as well as the effects of the flavonoid compositions Proteflazidum® and Protoil on the Nrf2 expression in these two experimental models of viral infection. Methods. Outbred white mice were infected with influenza A virus (A/FM/1/47/H1N1 strain). Jurkat cells were infected with TGEV, previously adapted to these cells. Flavonoid compositions Proteflazidum® and Protoil (Ecopharm, Ukraine), containing the mixture of tricin, luteolin, apigenin, quercetin, and rhamnosin, were used in corresponding dilutions. Real-Time PCR was employed to analyze Nrf2 RNA expression in the lungs of mice and in both uninfected and virus-infected cells. Additionally, ELISA was used to assess the expression of Nrf2 peptide. Results. The Nrf2 expression in the lungs of influenza virus-infected mice showed a tendency to increase within a 100-fold range. In virus-infected mice treated with Proteflazidum® or Protoil, the level of Nrf2 expression in the lungs decreased about 10-fold compared to infected untreated mice. TGEV infection resulted in 100-fold increase in Nrf2 expression in Jurkat cells. Both Proteflazidum® and Protoil decreased Nrf2 expression in TGEV-infected cells, while their effects on Nrf2 expression in the intact cells on Day 1 were not detected. Conclusions. Flavonoid compositions have only a slight effect on Nrf2 expression in intact cells. However, in case of virus infection, both in vivo and in vitro, they counteract the extensive up-regulation of Nrf2 expression due to viral infection.
- 12 November 2023
- Published by Igor Sikorsky Kyiv Polytechnic Institute in Innovative Biosystems and Bioengineering
- Vol. 7 (4) , 48-56
Open AccessThe Influence of Flavonoid Compositions on Nrf2 Transcription Factor Expression in Case of Infections Triggered by Influenza A Virus and Transmissible Gastroenteritis Coronavirus
Background. Viral infections trigger transcription factors, including Nrf2, which regulate the expression of genes related to cytokines, chemokines, and more. Nuclear factor erythroid 2-related factor 2 (Nrf2) participates in complex regulatory networks controlling the expression of cytoprotective genes and immune responses. Recently, new roles have been attributed to Nrf2, including the regulation of antiviral responses. Objective. The aim of the study was to analyze Nrf2 activation in influenza virus infection in vivo and in transmissible gastroenteritis coronavirus (TGEV) infection in vitro, as well as the effects of the flavonoid compositions Proteflazidum® and Protoil on the Nrf2 expression in these two experimental models of viral infection. Methods. Outbred white mice were infected with influenza A virus (A/FM/1/47/H1N1 strain). Jurkat cells were infected with TGEV, previously adapted to these cells. Flavonoid compositions Proteflazidum® and Protoil (Ecopharm, Ukraine), containing the mixture of tricin, luteolin, apigenin, quercetin, and rhamnosin, were used in corresponding dilutions. Real-Time PCR was employed to analyze Nrf2 RNA expression in the lungs of mice and in both uninfected and virus-infected cells. Additionally, ELISA was used to assess the expression of Nrf2 peptide. Results. The Nrf2 expression in the lungs of influenza virus-infected mice showed a tendency to increase within a 100-fold range. In virus-infected mice treated with Proteflazidum® or Protoil, the level of Nrf2 expression in the lungs decreased about 10-fold compared to infected untreated mice. TGEV infection resulted in 100-fold increase in Nrf2 expression in Jurkat cells. Both Proteflazidum® and Protoil decreased Nrf2 expression in TGEV-infected cells, while their effects on Nrf2 expression in the intact cells on Day 1 were not detected. Conclusions. Flavonoid compositions have only a slight effect on Nrf2 expression in intact cells. However, in case of virus infection, both in vivo and in vitro, they counteract the extensive up-regulation of Nrf2 expression due to viral infection.
- Open Access
- 4 June 2023
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Experimental Oncology
- Vol. 41 (3) , 207-209
Immunophenotypic features of leukemic stem cells and bulk of blasts in acute myeloid leukemia
Summary. According to the modern concept, leukemic stem cells (LSC) in acute myeloid leukemia (AML) are distinct from the bulk of leukemic cells in bone marrow and peripheral blood of AML patients. Nevertheless, LSC are responsible for managing all the hierarchy of the bulk of leukemic blast populations. This mini-review provides brief information on the distinctive features of LSC and blast cells in cytologically recognized types of AML. The study of different phenotypes of LSC and blast cells in AML with the aid of up-to-date flow cytometric techniques is important both for the deep insight into the mechanisms of leukemogenesis and development of novel strategies of target therapy. The urgent need for extending the diagnostic panel of monoclonal antibodies used for diagnosing AML is beyond doubt.
- 4 June 2023
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Experimental Oncology
- Vol. 41 (3) , 207-209
Open AccessImmunophenotypic features of leukemic stem cells and bulk of blasts in acute myeloid leukemia
Summary. According to the modern concept, leukemic stem cells (LSC) in acute myeloid leukemia (AML) are distinct from the bulk of leukemic cells in bone marrow and peripheral blood of AML patients. Nevertheless, LSC are responsible for managing all the hierarchy of the bulk of leukemic blast populations. This mini-review provides brief information on the distinctive features of LSC and blast cells in cytologically recognized types of AML. The study of different phenotypes of LSC and blast cells in AML with the aid of up-to-date flow cytometric techniques is important both for the deep insight into the mechanisms of leukemogenesis and development of novel strategies of target therapy. The urgent need for extending the diagnostic panel of monoclonal antibodies used for diagnosing AML is beyond doubt.
- Open Access
- 26 May 2023
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Experimental Oncology
- Vol. 43 (2) , 189-192
Long-term exposure to low doses of ionizing radiation and COVID-19 pandemic: oncohematological aspects
For more than 35 years after Chornobyl catastrophe, about 5 million people in Ukraine, Republic of Belarus and Russian Federation inhabit the territories that
- 26 May 2023
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Experimental Oncology
- Vol. 43 (2) , 189-192
Open AccessLong-term exposure to low doses of ionizing radiation and COVID-19 pandemic: oncohematological aspects
For more than 35 years after Chornobyl catastrophe, about 5 million people in Ukraine, Republic of Belarus and Russian Federation inhabit the territories that
- Open Access
- 26 May 2023
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Experimental Oncology
- Vol. 43 (1) , 87-91
Immunodeficiency-associated lymphoproliferative disorders and lymphoid neoplasms in post-COVID-19 pandemic era
The 2017 revision of WHO Classification of tumors of hematopoietic and lymphoid tissues contains separate chapters on the immunodeficiency-associated lymphoproliferative disorders. In this mini-review, the brief description of pathological, immunophenotypical and clinical features of lymphoid neoplasms associated with primary immune disorders, HIV infection, those arising in post-transplant setting and other lymphoproliferative disorders (excluding those induced by radiation) is given. The heterogeneous spectrum of these lymphoid malignancies is specified by the nature of those factors that are capable to induce immune suppression or chronic antigenic stimulation of immune system. Taking into account the full swing of SARS-CoV-2 pandemic and our ignorance of the ability of this virus to induce the sustained stimulation of immune system, we could not exclude the high risk of autoimmune diseases and lymphoid neoplasms in the long-term post-pandemic period. In this context, the role of angiotensin-converting enzyme 2 as well as some recently reported cell receptors for SARS-CoV-2 cell entry should be considered as far as some of them (CD147, CD26) could be tumor-associated antigens.
- 26 May 2023
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Experimental Oncology
- Vol. 43 (1) , 87-91
Open AccessImmunodeficiency-associated lymphoproliferative disorders and lymphoid neoplasms in post-COVID-19 pandemic era
The 2017 revision of WHO Classification of tumors of hematopoietic and lymphoid tissues contains separate chapters on the immunodeficiency-associated lymphoproliferative disorders. In this mini-review, the brief description of pathological, immunophenotypical and clinical features of lymphoid neoplasms associated with primary immune disorders, HIV infection, those arising in post-transplant setting and other lymphoproliferative disorders (excluding those induced by radiation) is given. The heterogeneous spectrum of these lymphoid malignancies is specified by the nature of those factors that are capable to induce immune suppression or chronic antigenic stimulation of immune system. Taking into account the full swing of SARS-CoV-2 pandemic and our ignorance of the ability of this virus to induce the sustained stimulation of immune system, we could not exclude the high risk of autoimmune diseases and lymphoid neoplasms in the long-term post-pandemic period. In this context, the role of angiotensin-converting enzyme 2 as well as some recently reported cell receptors for SARS-CoV-2 cell entry should be considered as far as some of them (CD147, CD26) could be tumor-associated antigens.
- Open Access
- 30 September 2020
- Published by OU Scientific Route in EUREKA: Life Sciences
- No. 5,p. 29-33
VILLOUS LYMPHOCYTES IN BLOOD AND BONE MARROW IN SOME FORMS OF B-CELL LYMPHOID MALIGNANCIES
The cytological and immunocytochemical features of the lymphocytes with villous morphology in peripheral blood and bone marrow in some B-lymphoproliferative disorders were studied. The diagnosis of hairy cell leukemia, a hairy cell leukemia variant, splenic marginal zone lymphoma and splenic diffuse red pulp small B-cell lymphoma was ascertained in accordance with the new revision of the WHO classification (2016). The neoplastic cells of hairy cell leukemia were determined by the presence of high tartrate resistant acid phosphatase (TRAP) activity. Cell surface expression of CD19, CD20 and CD21 antigens was detected. Also, the expression of CD25, CD103 and CD200, and in some cases cyclin D1, was found out. CD5, CD10 and CD23 were not detected. The immunophenotype of cells in splenic marginal zone lymphoma with villous processes also corresponded to the mature B cells. The expression of CD19, CD20 and CD21 was observed in all cases, CD11c – in 50% of patients, CD25 or CD5 – in 10% of patients. In 80% of patients, the pathologic cells did not show TRAP activity. In the bone marrow and peripheral blood cells of patients with diffuse red pulp lymphoma, TRAP activity was not detected. An immunophenotype in the hairy cell leukemia variant was different from those of classic HCL (CD19+CD20+CD22+CD103+CD11c+CD5–CD10–CD23–). Characterized immunophenotypical markers, which have differential diagnostic values in several forms of lymphoid tumors of B cell origin, will be important for the choice of treatment methods and prognosis
- 30 September 2020
- Published by OU Scientific Route in EUREKA: Life Sciences
- No. 5,p. 29-33
Open AccessVILLOUS LYMPHOCYTES IN BLOOD AND BONE MARROW IN SOME FORMS OF B-CELL LYMPHOID MALIGNANCIES
The cytological and immunocytochemical features of the lymphocytes with villous morphology in peripheral blood and bone marrow in some B-lymphoproliferative disorders were studied. The diagnosis of hairy cell leukemia, a hairy cell leukemia variant, splenic marginal zone lymphoma and splenic diffuse red pulp small B-cell lymphoma was ascertained in accordance with the new revision of the WHO classification (2016). The neoplastic cells of hairy cell leukemia were determined by the presence of high tartrate resistant acid phosphatase (TRAP) activity. Cell surface expression of CD19, CD20 and CD21 antigens was detected. Also, the expression of CD25, CD103 and CD200, and in some cases cyclin D1, was found out. CD5, CD10 and CD23 were not detected. The immunophenotype of cells in splenic marginal zone lymphoma with villous processes also corresponded to the mature B cells. The expression of CD19, CD20 and CD21 was observed in all cases, CD11c – in 50% of patients, CD25 or CD5 – in 10% of patients. In 80% of patients, the pathologic cells did not show TRAP activity. In the bone marrow and peripheral blood cells of patients with diffuse red pulp lymphoma, TRAP activity was not detected. An immunophenotype in the hairy cell leukemia variant was different from those of classic HCL (CD19+CD20+CD22+CD103+CD11c+CD5–CD10–CD23–). Characterized immunophenotypical markers, which have differential diagnostic values in several forms of lymphoid tumors of B cell origin, will be important for the choice of treatment methods and prognosis
- 19 May 2020
- Published by Springer Nature in Annals of Hematology
- Vol. 99 (7) , 1543-1550
Hematological malignancies in Ukraine in post-Chernobyl era: sources of data and their preliminary analysis
The major sources of the data on the hematological malignancies in the post-Chernobyl period in the regions of Ukraine differing by the levels of the residual contamination with radionuclides have been analyzed. According to the data collected from the primary hematological facilities in Ukraine in 2010–2017, the incidence of lymphoid neoplasms from mature B cells, acute myeloid leukemia, and multiple myeloma in the most contaminated regions was higher than in the less contaminated ones. For the first time, the relative contribution of the several specific types of leukemia in the total diagnosed hematological malignancies has been analyzed throughout 1997–2017 based on the in-house database compiled by the Reference Laboratory of RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, the National Academy of Sciences of Ukraine. In 2011–2017, the Reference Laboratory provided the diagnostic studies in about 26% of all Ukrainian patients with tumors of hematopoietic and lymphoid tissues (34% of patients with different forms of acute and chronic leukemia). The increased proportion of acute myeloid leukemia and chronic lymphocytic leukemia in the total diagnosed cases of overall leukemia in the patients from contaminated regions has been demonstrated following Chernobyl accident.
- 19 May 2020
- Published by Springer Nature in Annals of Hematology
- Vol. 99 (7) , 1543-1550
Hematological malignancies in Ukraine in post-Chernobyl era: sources of data and their preliminary analysis
The major sources of the data on the hematological malignancies in the post-Chernobyl period in the regions of Ukraine differing by the levels of the residual contamination with radionuclides have been analyzed. According to the data collected from the primary hematological facilities in Ukraine in 2010–2017, the incidence of lymphoid neoplasms from mature B cells, acute myeloid leukemia, and multiple myeloma in the most contaminated regions was higher than in the less contaminated ones. For the first time, the relative contribution of the several specific types of leukemia in the total diagnosed hematological malignancies has been analyzed throughout 1997–2017 based on the in-house database compiled by the Reference Laboratory of RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, the National Academy of Sciences of Ukraine. In 2011–2017, the Reference Laboratory provided the diagnostic studies in about 26% of all Ukrainian patients with tumors of hematopoietic and lymphoid tissues (34% of patients with different forms of acute and chronic leukemia). The increased proportion of acute myeloid leukemia and chronic lymphocytic leukemia in the total diagnosed cases of overall leukemia in the patients from contaminated regions has been demonstrated following Chernobyl accident.
- Open Access
- 30 June 2018
- Published by Institute of Molecular Biology and Genetics (NAS Ukraine) in Biopolymers and Cell
- Vol. 34 (3) , 218-228
Anti-HIV activity of ellagitannins from alder tree fruits
To assess the inhibitory activity of ellagitannin complex of the purified extract from the fruits of white alder and black alder in non-eukaryotic polymerase systems and to analyze the effects of these substances on the reverse transcriptase of murine leukemia virus and HIV reproduction in vitro. Methods. Chronically infected MT4/BIII culture of human leukemic cells was used as the HIV source. Anti-HIV activity of the ellagitannin-containing extract was estimated by the reduction of HIV infectious titer in the MT-4 cells. The inhibitory effects of the extract on retroviral reverse transcriptase, T7 RNA-polymerase and Taq polymerase were also studied in cell-free systems. Results. The ellagitannin extract inhibited activities of the reverse transcriptase of murine leukemia retrovirus, T7 RNA-polymerase, and Taq polymerase. It also reduced the HIV infectious titer in MT-4 cells with IC 50 of 1.5 μg/ml and selectivity index of 87. Conclusions. The ellagitannin complex possesses a significant anti-HIV activity. Its in vitro antiviral effect is achieved with a relatively low toxicity.
- 30 June 2018
- Published by Institute of Molecular Biology and Genetics (NAS Ukraine) in Biopolymers and Cell
- Vol. 34 (3) , 218-228
Open AccessAnti-HIV activity of ellagitannins from alder tree fruits
To assess the inhibitory activity of ellagitannin complex of the purified extract from the fruits of white alder and black alder in non-eukaryotic polymerase systems and to analyze the effects of these substances on the reverse transcriptase of murine leukemia virus and HIV reproduction in vitro. Methods. Chronically infected MT4/BIII culture of human leukemic cells was used as the HIV source. Anti-HIV activity of the ellagitannin-containing extract was estimated by the reduction of HIV infectious titer in the MT-4 cells. The inhibitory effects of the extract on retroviral reverse transcriptase, T7 RNA-polymerase and Taq polymerase were also studied in cell-free systems. Results. The ellagitannin extract inhibited activities of the reverse transcriptase of murine leukemia retrovirus, T7 RNA-polymerase, and Taq polymerase. It also reduced the HIV infectious titer in MT-4 cells with IC 50 of 1.5 μg/ml and selectivity index of 87. Conclusions. The ellagitannin complex possesses a significant anti-HIV activity. Its in vitro antiviral effect is achieved with a relatively low toxicity.
- 25 July 2015
- Published by Springer Nature in Annals of Hematology
- Vol. 94 (10) , 1639-1643
Myelodysplastic syndromes in Chernobyl clean-up workers
The studies of the recent decades posed the question of the association between radiation exposure and myelodysplastic syndromes (MDS). This association has been proved in secondary MDS originating upon exposure to chemotherapeutics and/or radiation therapy. The long-term study in Japanese atomic (A)-bomb survivors demonstrated the significant linear dose-response for MDS confirming the link between radiation exposure and this form of hematopoietic malignancies. All these findings provide the strong basis for studying MDS in the persons exposed to radiation following the Chernobyl disaster, especially those in the cohort of Chernobyl clean-up workers of 1986–1987. The data on MDS among Chernobyl clean-up workers (1986–1987) diagnosed in 1996–2012 at the reference laboratory of RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology are summarized. MDS cases were diagnosed in 23 persons (21 males and 2 females) having been exposed to radiation as clean-up workers of 1986–1987. Refractory anemia (RA) has been detected in 13, refractory anemia with ring sideroblasts (RARS)—in 2, and refractory anemia with excess blasts (RAEB)—in 8 patients. The median age of those MDS patients was 62.0 years. In addition, 5 cases of chronic myelomonocytic leukemia (CMML) were recorded in the group of Chernobyl clean-up workers with the median time of 14.8 years from 1986–1987 to diagnosis. The association between radiation exposure and MDS is discussed. The suggested life-long risk for myelodysplastic syndromes among A-bomb survivors in Japan highlights the importance of the continuing follow-up studies in the affected populations in the post-Chernobyl period.
- 25 July 2015
- Published by Springer Nature in Annals of Hematology
- Vol. 94 (10) , 1639-1643
Myelodysplastic syndromes in Chernobyl clean-up workers
The studies of the recent decades posed the question of the association between radiation exposure and myelodysplastic syndromes (MDS). This association has been proved in secondary MDS originating upon exposure to chemotherapeutics and/or radiation therapy. The long-term study in Japanese atomic (A)-bomb survivors demonstrated the significant linear dose-response for MDS confirming the link between radiation exposure and this form of hematopoietic malignancies. All these findings provide the strong basis for studying MDS in the persons exposed to radiation following the Chernobyl disaster, especially those in the cohort of Chernobyl clean-up workers of 1986–1987. The data on MDS among Chernobyl clean-up workers (1986–1987) diagnosed in 1996–2012 at the reference laboratory of RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology are summarized. MDS cases were diagnosed in 23 persons (21 males and 2 females) having been exposed to radiation as clean-up workers of 1986–1987. Refractory anemia (RA) has been detected in 13, refractory anemia with ring sideroblasts (RARS)—in 2, and refractory anemia with excess blasts (RAEB)—in 8 patients. The median age of those MDS patients was 62.0 years. In addition, 5 cases of chronic myelomonocytic leukemia (CMML) were recorded in the group of Chernobyl clean-up workers with the median time of 14.8 years from 1986–1987 to diagnosis. The association between radiation exposure and MDS is discussed. The suggested life-long risk for myelodysplastic syndromes among A-bomb survivors in Japan highlights the importance of the continuing follow-up studies in the affected populations in the post-Chernobyl period.